FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293770124> ?p ?o ?g. }

• W4293770124 abstract "Autologous stem cell transplantation (ASCT) remains the standard of care for patients with newly diagnosed multiple myeloma (MM). Several attempts to improve the efficacy of conditioning regimens have been conducted in MM, but no more effective regimen than conventional high-dose melphalan has been introduced.In this study, the efficacy and toxicity of busulfan and thiotepa (BuTT) and those of high-dose melphalan (HD-MEL) were compared retrospectively as a conditioning regimen for ASCT in patients with MM.Included in the analysis were 114 patients who received BuTT and 114 patients who received HD-MEL treatment between March 2008 and May 2020. The BuTT regimen consisted of intravenous thiotepa 5 mg/kg once a day from days 7 to 6, followed by intravenous busulfan 3.2 mg/kg once a day from days 5 to 3. The HD-MEL conditioning regimen consisted of melphalan 100 mg/m2 once a day from days 3 to 2.The overall response rate after ASCT did not differ between BuTT and HD-MEL (94.7% in BuTT vs. 97.4% in HD-MEL, p = 0.333). After a median follow-up of 47.6 months, progression-free survival (PFS) tended to be longer in the BuTT group (median PFS, 41.5 months vs. 30.3 months; hazard ratio (HR), 0.706; 95% confidence interval (CI), 0.497-1.004, p = 0.053). In the subgroup analysis of patients who did not proceed to maintenance or consolidation treatment after ASCT, the difference in PFS became more significant (median PFS, 41.5 months vs. 24.4 months; HR, 0.621; 95% CI, 0.388-0.993; p = 0.047). Additionally, the BuTT group had fewer adverse events, such as grade 3 or 4 stomatitis and diarrhea, than the HD-MEL group (stomatitis, 10.5% vs. 23.7%, p = 0.013; diarrhea, 10.5% vs. 25.4%, p = 0.005). There was no difference in the occurrence of venous-occlusive disease (2.6% in BuTT vs. 0.9% in HD-MEL, p = 0.622).Our study results suggest that BuTT is an effective alternative conditioning regimen with reduced toxicity in patients with newly diagnosed MM." @default.
• W4293770124 created "2022-08-31" @default.
• W4293770124 creator A5014597278 @default.
• W4293770124 creator A5020574847 @default.
• W4293770124 creator A5022259689 @default.
• W4293770124 creator A5034751203 @default.
• W4293770124 creator A5036888293 @default.
• W4293770124 creator A5041987846 @default.
• W4293770124 creator A5043460941 @default.
• W4293770124 creator A5068416755 @default.
• W4293770124 creator A5088824120 @default.
• W4293770124 date "2022-08-30" @default.
• W4293770124 modified "2023-10-09" @default.
• W4293770124 title "Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)" @default.
• W4293770124 cites W1589566672 @default.
• W4293770124 cites W1703963147 @default.
• W4293770124 cites W1833666995 @default.
• W4293770124 cites W1965234287 @default.
• W4293770124 cites W1966771497 @default.
• W4293770124 cites W1969875820 @default.
• W4293770124 cites W1972172571 @default.
• W4293770124 cites W2001813071 @default.
• W4293770124 cites W2032640560 @default.
• W4293770124 cites W2044225326 @default.
• W4293770124 cites W2056645074 @default.
• W4293770124 cites W2066181884 @default.
• W4293770124 cites W2075175599 @default.
• W4293770124 cites W2079685513 @default.
• W4293770124 cites W2080264915 @default.
• W4293770124 cites W2093908955 @default.
• W4293770124 cites W2094515731 @default.
• W4293770124 cites W2107249625 @default.
• W4293770124 cites W2128192762 @default.
• W4293770124 cites W2465127936 @default.
• W4293770124 cites W2486629951 @default.
• W4293770124 cites W2512261371 @default.
• W4293770124 cites W2772193704 @default.
• W4293770124 cites W2898897947 @default.
• W4293770124 cites W2940396472 @default.
• W4293770124 cites W3037214851 @default.
• W4293770124 cites W4223563416 @default.
• W4293770124 cites W4232256781 @default.
• W4293770124 doi "https://doi.org/10.3389/fonc.2022.959949" @default.
• W4293770124 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36110935" @default.
• W4293770124 hasPublicationYear "2022" @default.
• W4293770124 type Work @default.
• W4293770124 citedByCount "3" @default.
• W4293770124 countsByYear W42937701242022 @default.
• W4293770124 countsByYear W42937701242023 @default.
• W4293770124 crossrefType "journal-article" @default.
• W4293770124 hasAuthorship W4293770124A5014597278 @default.
• W4293770124 hasAuthorship W4293770124A5020574847 @default.
• W4293770124 hasAuthorship W4293770124A5022259689 @default.
• W4293770124 hasAuthorship W4293770124A5034751203 @default.
• W4293770124 hasAuthorship W4293770124A5036888293 @default.
• W4293770124 hasAuthorship W4293770124A5041987846 @default.
• W4293770124 hasAuthorship W4293770124A5043460941 @default.
• W4293770124 hasAuthorship W4293770124A5068416755 @default.
• W4293770124 hasAuthorship W4293770124A5088824120 @default.
• W4293770124 hasBestOaLocation W42937701241 @default.
• W4293770124 hasConcept C126322002 @default.
• W4293770124 hasConcept C141071460 @default.
• W4293770124 hasConcept C143998085 @default.
• W4293770124 hasConcept C207103383 @default.
• W4293770124 hasConcept C2776364478 @default.
• W4293770124 hasConcept C2776694085 @default.
• W4293770124 hasConcept C2776755627 @default.
• W4293770124 hasConcept C2777408962 @default.
• W4293770124 hasConcept C2778684742 @default.
• W4293770124 hasConcept C2779050716 @default.
• W4293770124 hasConcept C2779968505 @default.
• W4293770124 hasConcept C2780611847 @default.
• W4293770124 hasConcept C2781413609 @default.
• W4293770124 hasConcept C2911091166 @default.
• W4293770124 hasConcept C44249647 @default.
• W4293770124 hasConcept C71924100 @default.
• W4293770124 hasConceptScore W4293770124C126322002 @default.
• W4293770124 hasConceptScore W4293770124C141071460 @default.
• W4293770124 hasConceptScore W4293770124C143998085 @default.
• W4293770124 hasConceptScore W4293770124C207103383 @default.
• W4293770124 hasConceptScore W4293770124C2776364478 @default.
• W4293770124 hasConceptScore W4293770124C2776694085 @default.
• W4293770124 hasConceptScore W4293770124C2776755627 @default.
• W4293770124 hasConceptScore W4293770124C2777408962 @default.
• W4293770124 hasConceptScore W4293770124C2778684742 @default.
• W4293770124 hasConceptScore W4293770124C2779050716 @default.
• W4293770124 hasConceptScore W4293770124C2779968505 @default.
• W4293770124 hasConceptScore W4293770124C2780611847 @default.
• W4293770124 hasConceptScore W4293770124C2781413609 @default.
• W4293770124 hasConceptScore W4293770124C2911091166 @default.
• W4293770124 hasConceptScore W4293770124C44249647 @default.
• W4293770124 hasConceptScore W4293770124C71924100 @default.
• W4293770124 hasLocation W42937701241 @default.
• W4293770124 hasLocation W42937701242 @default.
• W4293770124 hasLocation W42937701243 @default.
• W4293770124 hasLocation W42937701244 @default.
• W4293770124 hasOpenAccess W4293770124 @default.
• W4293770124 hasPrimaryLocation W42937701241 @default.
• W4293770124 hasRelatedWork W2038050731 @default.
• W4293770124 hasRelatedWork W2091346949 @default.

• next